BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9464301)

  • 21. Histological observations one year after mechanochemical endovenous ablation of the great saphenous vein.
    van Eekeren RR; Hillebrands JL; van der Sloot K; de Vries JP; Zeebregts CJ; Reijnen MM
    J Endovasc Ther; 2014 Jun; 21(3):429-33. PubMed ID: 24915593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three cases of stroke following peripheral venous interventions.
    Ma RW; Pilotelle A; Paraskevas P; Parsi K
    Phlebology; 2011 Oct; 26(7):280-4. PubMed ID: 21422195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in calf muscle deoxygenation after foam sclerotherapy in patients with superficial venous insufficiency.
    Yamaki T; Konoeda H; Fujisawa D; Ogino K; Osada A; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg; 2012 Dec; 56(6):1649-55. PubMed ID: 22608181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.
    Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B
    Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sclerotherapy of the internal saphenous vein in the standing and sitting position. A comparative study].
    Raymond-Martimbeau P
    Phlebologie; 1991; 44(1):97-107; discussion 107-10. PubMed ID: 1946660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter.
    Brodersen JP; Geismar U
    Dermatol Surg; 2007 Apr; 33(4):469-75. PubMed ID: 17430382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regarding "Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation".
    Morrison N
    J Vasc Surg; 2008 Mar; 47(3):693. PubMed ID: 18295125
    [No Abstract]   [Full Text] [Related]  

  • 29. Compression sclerotherapy in venous insufficiency.
    Hobbs JT
    Acta Chir Scand Suppl; 1988; 544():75-80. PubMed ID: 3176809
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
    Tessari L; Cavezzi A; Frullini A
    Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy.
    Almeida JI; Raines JK
    Dermatol Surg; 2007 Sep; 33(9):1037-44; discussion 1044. PubMed ID: 17760594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immediate and transient faintness following a course of foam sclerotherapy treatment for saphenous vein incompetence in an elderly patient.
    Rastel D
    J Mal Vasc; 2016 Dec; 41(6):412-415. PubMed ID: 27815001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
    Tan KT; Kirby J; Rajan DK; Hayeems E; Beecroft JR; Simons ME
    J Vasc Interv Radiol; 2007 Mar; 18(3):343-51. PubMed ID: 17377179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective five-year study of ultrasound-guided foam sclerotherapy in the treatment of great saphenous vein reflux.
    Chapman-Smith P; Browne A
    Phlebology; 2009 Aug; 24(4):183-8. PubMed ID: 19620701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
    Khandpur S; Sharma VK
    Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endovascular radiofrequency ablation: a novel treatment of venous insufficiency in Klippel-Trenaunay patients.
    Frasier K; Giangola G; Rosen R; Ginat DT
    J Vasc Surg; 2008 Jun; 47(6):1339-45. PubMed ID: 18514850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anatomical and clinical factors favoring the performance of saphenous ablation and microphlebectomy or sclerotherapy as a single-stage procedure.
    Kokkosis AA; Schanzer H
    Phlebology; 2015 Oct; 30(9):627-31. PubMed ID: 25300313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Duplex system in the follow-up of sclerosing therapy of the greater saphenous vein. First results and considerations].
    Gongolo A; Giraldi E; Buttazzoni L; Spreafico G; Pinzani A; Ravasini R; Pavei P
    Radiol Med; 1991 Mar; 81(3):303-8. PubMed ID: 2014337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel treatment of sialocele with sodium tetradecyl sclerotherapy.
    Lee E; Magge H; Thakkar PG; Joshi A
    Am J Otolaryngol; 2021; 42(5):103031. PubMed ID: 33873047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.